Detalhe da pesquisa
1.
Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.
JACC Asia;
4(5): 403-417, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38765657
2.
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Int J Rheum Dis;
27(5): e15178, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742751
3.
The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial.
Respir Investig;
62(4): 589-596, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692040
4.
Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis.
Rheumatol Adv Pract;
8(2): rkae049, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38708024
5.
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study).
Pharmaceuticals (Basel);
17(5)2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38794126
6.
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Int J Rheum Dis;
27(5): e15161, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720408
7.
Lung ultrasound in the assessment of interstitial lung disease in patients with connective tissue disease: Performance in comparison with high-resolution computed tomography.
Mod Rheumatol;
2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38813668
8.
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Rheumatol Int;
2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609655
9.
Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus.
Mod Rheumatol;
2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38590037
10.
Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al.
Ann Rheum Dis;
2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548314
11.
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.
Rheumatol Adv Pract;
8(2): rkae028, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38524696
12.
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
Clin Exp Rheumatol;
42(2): 277-287, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488094
13.
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
Clin Exp Rheumatol;
42(2): 403-412, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436279
14.
Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study.
Rheumatology (Oxford);
2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430474
15.
Pre-scleroderma and new opportunities for preventive medicine - Authors' reply.
Lancet Rheumatol;
6(4): e201, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508819
16.
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
Rheumatol Int;
44(5): 805-817, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470502
17.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford);
2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460548
18.
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.
Am J Hematol;
99(2): E55-E59, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165064
19.
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
Rheumatology (Oxford);
63(1): 127-139, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084267
20.
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Rheumatol Int;
44(1): 73-80, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060005